Benitec Biopharma's total assets for Q3 2025 were $105.21M, an increase of 33.06% from the previous quarter. BNTC total liabilities were $7.64M for the fiscal quarter, a 144.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.